GLOUCESTER PHARMACEUTICALS has a total of 12 patent applications. Its first patent ever was published in 2007. It filed its patents most often in WIPO (World Intellectual Property Organization), Mexico and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are ADVANCED OCULAR SYSTEMS LTD, ASCENDIS PHARMA BONE DISEASES AS and CONARIS RES INSTITUTE AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Mexico | 2 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Fermentation | |
#5 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Keegan Mitchell | 8 |
#2 | Mcculloch William | 4 |
#3 | Cluse Leonie | 3 |
#4 | Johnstone Ricky W | 3 |
#5 | Newbold Andrea | 3 |
#6 | Verdine Gregory L | 3 |
#7 | Bates Susan E | 2 |
#8 | Vrolijk Nicholas H | 2 |
#9 | Piekarz Richard L | 2 |
#10 | Bertel Stephan | 1 |
Publication | Filing date | Title |
---|---|---|
CA2741265A1 | Cancer therapy | |
WO2008083290A1 | Romidepsin-based treatments for cancer | |
WO2007146730A2 | Deacetylase inhibitor therapy | |
US2010137239A1 | Gemcitabine combination therapy | |
WO2008088331A1 | Methods for increasing levels of human fetal hemoglobin |